Literature DB >> 7921126

Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome.

J Vajsar1, A Sloane, E Wood, E G Murphy.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7921126     DOI： 10.1001/archpedi.1994.02170110096019

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN： 1072-4710


× No keyword cloud information.
  5 in total

1.  Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

Authors:  G DelGiudice-Asch; L Simon; J Schmeidler; C Cunningham-Rundles; E Hollander
Journal:  J Autism Dev Disord       Date:  1999-04

Review 2.  IVIG therapy in neurological disorders of childhood.

Authors:  Juan J Archelos; Franz Fazekas
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Intravenous immunoglobulins in severe Guillian-Barre syndrome in childhood.

Authors:  Preeti Shanbag; Cynthia Amirtharaj; Ashish Pathak
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

4.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

Review 5.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.